Evidence map›Paper›PMID 28168055›Full record

ArticleBiochemistry research international2017

In Vitro and In Vivo Effects of Norathyriol and Mangiferin on

Zhi-Long Shi, Yi-Dan Liu, Yun-Yun Yuan, Da Song, Mei-Feng Qi, Xu-Juan Yang, Ping Wang, Xiao-Ying Li, Jian-Hua Shang, Zhao-Xiang Yang

Open access · goldAbstract read
In one paragraph

Article in Biochemistry research international, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
4.7field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 32 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Breast cancer (Dove Medical Press) · 2021
    Review
  6. Article
  7. Antioxidants (Basel, Switzerland) · 2020
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 1 institution in 1 country.

Zhi-Long ShiYunnan University of Traditional Chinese Medicine, Kunming 650500, China.
Yi-Dan LiuInstitute of Drug Discovery & Development, Kunming Pharmaceutical Corporation, Kunming 650106, China.
Yun-Yun YuanYunnan University of Traditional Chinese Medicine, Kunming 650500, China.
Da SongYunnan University of Traditional Chinese Medicine, Kunming 650500, China.
Mei-Feng QiYunnan University of Traditional Chinese Medicine, Kunming 650500, China.
Xu-Juan YangInstitute of Drug Discovery & Development, Kunming Pharmaceutical Corporation, Kunming 650106, China.
Ping WangInstitute of Drug Discovery & Development, Kunming Pharmaceutical Corporation, Kunming 650106, China.
Xiao-Ying LiInstitute of Drug Discovery & Development, Kunming Pharmaceutical Corporation, Kunming 650106, China.
Jian-Hua ShangYunnan University of Traditional Chinese Medicine, Kunming 650500, China; Institute of Drug Discovery & Development, Kunming Pharmaceutical Corporation, Kunming 650106, China.ORCID 0000-0003-0222-086X
Zhao-Xiang YangInstitute of Drug Discovery & Development, Kunming Pharmaceutical Corporation, Kunming 650106, China.ORCID 0000-0001-6882-2236
Yunnan University of Traditional Chinese Medicine · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Norathyriol is a metabolite of mangiferin. Mangiferin has been reported to inhibit

Identifiers

PMID28168055
PMCPMC5259675
OpenAlexW2570219755

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.